Compound ID | 967
Class: Beta-lactamase inhibitor (methylcarbapenem)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Combined with other compounds: | Tested pairing with imipenem showed for IMP-1 producing clinical isolateds reduced MICs |
| Institute where first reported: | Banyu Pharmaceutical Co. Ltd.( Merck & Co, USA) |
| Year first mentioned: | 1999 |
| Highest development stage: | Preclinical |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9822198 |
| Citation: | https://journals.asm.org/doi/full/10.1128/AAC.43.10.2497 |